Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib

le Qin, Jim S., Johnstone, Timothy G., Baturevych, Alex, Hause, Ronald J., Ragan, Seamus P., Clouser, Christopher R., Jones, Jon C., Ponce, Rafael, Krejsa, Cecile M., Salmon, Ruth A., Ports, Michael O.
Foilsithe in J Immunother (2020)

A Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation

le Scalley-Kim, Michelle L., Hess, Bruce W., Kelly, Ryan L., Krostag, Anne-Rachel F., Lustig, Kurt H., Marken, John S., Ovendale, Pamela J., Posey, Aaron R., Smolak, Pamela J., Taylor, Janelle D. L., Wood, C. L., Bienvenue, David L., Probst, Peter, Salmon, Ruth A., Allison, Daniel S., Foy, Teresa M., Raport, Carol J.
Foilsithe 2012